Karen Heslop
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Karen Heslop has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Dianne Wynaden
Curtin University (Nursing & Midwifery), Perth, Western Australia, Australia
18 shared publications - Barbara Mullan
School of Population Health Curtin University Bentley Western Australia Australia
6 shared publications - Darren Haywood
Human Performance Research Centre, INSIGHT Research Institute, Faculty of Health, University of Technology Sydney (UTS), Sydney, Australia
6 shared publications - Eric Lim
University of Newcastle Callaghan New South Wales Australia
6 shared publications - Frank D. Baughman
Neurocognitive Developmental Laboratory, School of Population Health Curtin University Perth Western Australia Australia
5 shared publications - Omar Al Omari
College of Nursing, Sultan Qaboos University, Muscat, Oman
5 shared publications
Latest Publications
- 11 December 2025
- Published by Taylor & Francis in Drugs: Education, Prevention and Policy
- Vol. 33 (6) , 700-712
Injecting hope: a novel community pharmacy needle syringe program providing monetary incentives and free needle packs to promote hepatitis C screening
- 11 December 2025
- Published by Taylor & Francis in Drugs: Education, Prevention and Policy
- Vol. 33 (6) , 700-712
Injecting hope: a novel community pharmacy needle syringe program providing monetary incentives and free needle packs to promote hepatitis C screening
- 5 November 2025
- Published by Wiley in International Journal of Mental Health Nursing
- Vol. 34 (6) , e70172
Diagnostic Overshadowing of Chronic Hepatitis C in People With Mental Health Conditions Who Inject Drugs: A Scoping Review
- 5 November 2025
- Published by Wiley in International Journal of Mental Health Nursing
- Vol. 34 (6) , e70172
Diagnostic Overshadowing of Chronic Hepatitis C in People With Mental Health Conditions Who Inject Drugs: A Scoping Review
- Open Access
- 27 September 2025
- Published by Taylor & Francis in Drugs: Education, Prevention and Policy
- Vol. 33 (3) , 383-394
Cupping a solution: ‘screening from a cup’ incentive for hepatitis C in community program for opioid pharmacotherapy clients
- 27 September 2025
- Published by Taylor & Francis in Drugs: Education, Prevention and Policy
- Vol. 33 (3) , 383-394
Open AccessCupping a solution: ‘screening from a cup’ incentive for hepatitis C in community program for opioid pharmacotherapy clients
- Open Access
- 11 July 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (7) , e71039
From Education to Action—The Impact of Hepatitis C Micro‐Elimination Education on Healthcare Provider Confidence and Linkage to Care: A Quasi‐Experimental Study
Background and Aim: Micro‐elimination education can improve access to life‐saving treatments for patients with hepatitis C, co‐occurring mental health conditions, and alcohol and other drug use disorders. The Hepatitis C virus (HCV) is disproportionately prevalent among people with mental health conditions and alcohol and other drug issues, reducing their life expectancy. Although hepatitis C is a curable condition, this population frequently remains untested and untreated. Micro‐elimination programs are necessary to enhance hepatitis C virus screening and treatment rates. This study aims to evaluate the impact of micro‐elimination education on healthcare providers' confidence in identifying high‐risk HCV populations, conducting HCV screenings and treatments, and managing comorbid substance use disorders. Additionally, it will assess referrals to a nurse‐led HCV treatment clinic. Methods: A quasi‐experimental pre‐posttest intervention design was used. The intervention was an education program targeted at HCV micro‐elimination and linkage to care. Results: Questionnaires were administered to ( n = 101) healthcare providers to measure changes in confidence in screening and treating HCV in people with comorbid mental health conditions and alcohol and other drug disorders pre‐ and post‐intervention. Pre‐intervention, healthcare providers reported the highest confidence levels in treating mental health conditions. A significant increase in post‐education confidence in screening and treating the HCV across all healthcare provider roles was observed ( p < 0.05). Twenty‐three referrals were received at the nurse‐led hepatitis C virus treatment clinic, with the majority ( n = 11) of referrals received from nurses. Conclusion: This study underscores the significance of micro‐elimination education programs in enhancing healthcare provider confidence in treating hepatitis C. Leveraging the mental health nursing workforce to connect high‐risk populations with hepatitis C care will expand timely access to life‐saving treatments and optimize healthcare outcomes. Targeted hepatitis C micro‐elimination education will further accelerate progress toward the 2030 elimination goals, enhancing the overall well‐being of vulnerable populations.
- 11 July 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (7) , e71039
Open AccessFrom Education to Action—The Impact of Hepatitis C Micro‐Elimination Education on Healthcare Provider Confidence and Linkage to Care: A Quasi‐Experimental Study
Background and Aim: Micro‐elimination education can improve access to life‐saving treatments for patients with hepatitis C, co‐occurring mental health conditions, and alcohol and other drug use disorders. The Hepatitis C virus (HCV) is disproportionately prevalent among people with mental health conditions and alcohol and other drug issues, reducing their life expectancy. Although hepatitis C is a curable condition, this population frequently remains untested and untreated. Micro‐elimination programs are necessary to enhance hepatitis C virus screening and treatment rates. This study aims to evaluate the impact of micro‐elimination education on healthcare providers' confidence in identifying high‐risk HCV populations, conducting HCV screenings and treatments, and managing comorbid substance use disorders. Additionally, it will assess referrals to a nurse‐led HCV treatment clinic. Methods: A quasi‐experimental pre‐posttest intervention design was used. The intervention was an education program targeted at HCV micro‐elimination and linkage to care. Results: Questionnaires were administered to ( n = 101) healthcare providers to measure changes in confidence in screening and treating HCV in people with comorbid mental health conditions and alcohol and other drug disorders pre‐ and post‐intervention. Pre‐intervention, healthcare providers reported the highest confidence levels in treating mental health conditions. A significant increase in post‐education confidence in screening and treating the HCV across all healthcare provider roles was observed ( p < 0.05). Twenty‐three referrals were received at the nurse‐led hepatitis C virus treatment clinic, with the majority ( n = 11) of referrals received from nurses. Conclusion: This study underscores the significance of micro‐elimination education programs in enhancing healthcare provider confidence in treating hepatitis C. Leveraging the mental health nursing workforce to connect high‐risk populations with hepatitis C care will expand timely access to life‐saving treatments and optimize healthcare outcomes. Targeted hepatitis C micro‐elimination education will further accelerate progress toward the 2030 elimination goals, enhancing the overall well‐being of vulnerable populations.
- 18 March 2025
- Published by Taylor & Francis in Issues in Mental Health Nursing
- Vol. 46 (6) , 638-641
Presence in Mental Health Nursing
- 18 March 2025
- Published by Taylor & Francis in Issues in Mental Health Nursing
- Vol. 46 (6) , 638-641
Presence in Mental Health Nursing
- Open Access
- 5 August 2024
- Published by Wiley in International Journal of Mental Health Nursing
- Vol. 33 (6) , 1840-1873
Diagnostic Overshadowing of Chronic Hepatitis C in People With Mental Health Conditions Who Inject Drugs: A Scoping Review
Diagnostic overshadowing refers to a phenomenon whereby people with mental health conditions encounter inadequate or delayed medical attention and misdiagnosis. This occurs when physical symptoms are mistakenly attributed to their mental health condition. This paper presents a scoping review focusing on direct causes and background factors of diagnostic overshadowing in the context of hepatitis C infection in people who inject drugs and have concurrent mental health conditions. Despite significant strides in hepatitis C treatment with direct‐acting antiviral drugs, the complex interplay of mental health conditions and physical symptoms necessitates a nuanced approach for accurate diagnosis and effective screening. This review was conducted using Joanna Briggs Institute's methodology for scoping reviews. The databases searched included Medline, Embase, PsycInfo, Global Health, CINAHL and Scopus. This review followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for Scoping Reviews (PRISMA‐ScR). The search strategies identified 1995 records. Overall, 166 studies were excluded. Forty‐two (42) studies met the inclusion criteria. Three (n = 3) studies represented direct causes, and 39 (n = 39) with background factors related to diagnostic overshadowing. Studies highlighted six key themes encompassing diagnostic overshadowing, with communication barriers, stigma and knowledge deficiencies being the most prominent. Recognising and addressing diagnostic overshadowing in chronic hepatitis C will lead to increased screening, diagnosis and timely administration of life‐saving antiviral therapy, resulting in profound enhancements in well‐being and health outcomes. Moreover, this proactive approach will play a pivotal role in advancing the global effort towards eliminating hepatitis C by 2030.
- 5 August 2024
- Published by Wiley in International Journal of Mental Health Nursing
- Vol. 33 (6) , 1840-1873
Open AccessDiagnostic Overshadowing of Chronic Hepatitis C in People With Mental Health Conditions Who Inject Drugs: A Scoping Review
Diagnostic overshadowing refers to a phenomenon whereby people with mental health conditions encounter inadequate or delayed medical attention and misdiagnosis. This occurs when physical symptoms are mistakenly attributed to their mental health condition. This paper presents a scoping review focusing on direct causes and background factors of diagnostic overshadowing in the context of hepatitis C infection in people who inject drugs and have concurrent mental health conditions. Despite significant strides in hepatitis C treatment with direct‐acting antiviral drugs, the complex interplay of mental health conditions and physical symptoms necessitates a nuanced approach for accurate diagnosis and effective screening. This review was conducted using Joanna Briggs Institute's methodology for scoping reviews. The databases searched included Medline, Embase, PsycInfo, Global Health, CINAHL and Scopus. This review followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for Scoping Reviews (PRISMA‐ScR). The search strategies identified 1995 records. Overall, 166 studies were excluded. Forty‐two (42) studies met the inclusion criteria. Three (n = 3) studies represented direct causes, and 39 (n = 39) with background factors related to diagnostic overshadowing. Studies highlighted six key themes encompassing diagnostic overshadowing, with communication barriers, stigma and knowledge deficiencies being the most prominent. Recognising and addressing diagnostic overshadowing in chronic hepatitis C will lead to increased screening, diagnosis and timely administration of life‐saving antiviral therapy, resulting in profound enhancements in well‐being and health outcomes. Moreover, this proactive approach will play a pivotal role in advancing the global effort towards eliminating hepatitis C by 2030.
- Open Access
- 5 June 2024
- Published by Bentham Science Publishers Ltd. in The Open Urology & Nephrology Journal
- Vol. 17 (1)
Comparison of Factors Affecting the Immune Response to Hepatitis B Vaccination in Patients with Stage 5 Chronic Kidney Disease-haemodialysis and Predialysis
Aim: To evaluate the factors that affect the immune response to Hepatitis B vaccination in the Stage 5 chronic kidney disease population (Haemodialysis and Predialysis). Methods: Eligible Stage 5 chronic kidney disease patients on haemodialysis (Cohort A: N= 39) and Predialysis (Cohort B: N=56) in an outer metropolitan renal service in Western Australia with no prior Hepatitis B infection or vaccination between Jan 2015 to Dec 2021 were involved in this retrospective cohort study. Serological response to Hepatitis B vaccination (H-B-VAX II 40 mcg intramuscularly at 0, 1 and 6 months) was evaluated six-eight weeks post-vaccination. Factors such as age, gender, diabetes mellites, cardiovascular disease, hypertension, chronic obstructive airway disease, serum albumin, and erythropoietin stimulating agent dependence were studied for their influence on immune responses in these cohorts. Results: There were 95 eligible respondents in the study. Cohort B (Predialysis) showed a significantly higher response than Cohort A (Haemodialysis) (66.1% vs 53.8%) (p=0.003). Different factors affecting the vaccine response were identified in the two cohorts. Serum albumin <35g/L was associated with negative response in 61.1% (p =0.0023)Cohort A HD patients. In the Predialysis Cohort B, 84.2%(p=0.026) were male gender, 63.2%(p=0.028) with the presence of cardiovascular disease, and 57.9%(p=0.001) who were Erythropoietin dependent showed a negative response to the vaccine. Conclusion: This study showed that the Hepatitis B vaccine response was lower in HD patients than in Predialysis patients with stage 5 chronic kidney disease. Clinical factors of serum albumin, cardiovascular disease, and patient factors of gender and erythropoietin dependence were identified as factors that affected vaccine response in these two cohorts. We postulate these factors to be considered in the hepatitis B vaccination management to enhance immunological response strategies and extend to earlier stages of chronic kidney failure.
- 5 June 2024
- Published by Bentham Science Publishers Ltd. in The Open Urology & Nephrology Journal
- Vol. 17 (1)
Open AccessComparison of Factors Affecting the Immune Response to Hepatitis B Vaccination in Patients with Stage 5 Chronic Kidney Disease-haemodialysis and Predialysis
Aim: To evaluate the factors that affect the immune response to Hepatitis B vaccination in the Stage 5 chronic kidney disease population (Haemodialysis and Predialysis). Methods: Eligible Stage 5 chronic kidney disease patients on haemodialysis (Cohort A: N= 39) and Predialysis (Cohort B: N=56) in an outer metropolitan renal service in Western Australia with no prior Hepatitis B infection or vaccination between Jan 2015 to Dec 2021 were involved in this retrospective cohort study. Serological response to Hepatitis B vaccination (H-B-VAX II 40 mcg intramuscularly at 0, 1 and 6 months) was evaluated six-eight weeks post-vaccination. Factors such as age, gender, diabetes mellites, cardiovascular disease, hypertension, chronic obstructive airway disease, serum albumin, and erythropoietin stimulating agent dependence were studied for their influence on immune responses in these cohorts. Results: There were 95 eligible respondents in the study. Cohort B (Predialysis) showed a significantly higher response than Cohort A (Haemodialysis) (66.1% vs 53.8%) (p=0.003). Different factors affecting the vaccine response were identified in the two cohorts. Serum albumin <35g/L was associated with negative response in 61.1% (p =0.0023)Cohort A HD patients. In the Predialysis Cohort B, 84.2%(p=0.026) were male gender, 63.2%(p=0.028) with the presence of cardiovascular disease, and 57.9%(p=0.001) who were Erythropoietin dependent showed a negative response to the vaccine. Conclusion: This study showed that the Hepatitis B vaccine response was lower in HD patients than in Predialysis patients with stage 5 chronic kidney disease. Clinical factors of serum albumin, cardiovascular disease, and patient factors of gender and erythropoietin dependence were identified as factors that affected vaccine response in these two cohorts. We postulate these factors to be considered in the hepatitis B vaccination management to enhance immunological response strategies and extend to earlier stages of chronic kidney failure.
- 15 February 2023
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 58 (5) , 629-636
Do Dimensional Measures of Mental Health Symptoms Predict Level of Alcohol Involvement in the General Population?
Background: There is a limited understanding of what specific mental health symptoms are associated to alcohol involvement. It is important to understand how the severity of different mental health dimensions may differ, and distinguish between, levels of alcohol involvement. Objectives: (a) explore for differences in severity of mental health symptoms between those with lower, and moderate/high alcohol involvement, (b) assess the degree to which mental health dimensions can distinguish between those with lower, and moderate/high alcohol involvement, and (c) examine what mental health dimensions are related to the highest risk of moderate/high alcohol involvement. Results: 400 participants representative of the general population in the USA were recruited online through Prolific and completed the Alcohol, Smoking and Substance Involvement Screening Test and Brief Symptom Inventory. Each of the nine mental health symptom dimensions significantly differed between lower and moderate/high alcohol involvement, with the moderate/high alcohol involvement group reporting greater severity symptoms. The nine symptom dimensions in combination also significantly distinguished lower and moderate/high alcohol involvement, however only somatization offered unique predictive utility. Lastly, global distress was also able to significantly distinguish the alcohol involvement groups, albeit to a lesser accuracy compared to the collection of individual symptom dimensions. Conclusions: These findings suggest that overall mental health distress may be important to understanding alcohol involvement, however individual symptom dimensions can add further explanatory variance. In particular, somatic symptoms may offer unique utility in understanding the relationship between mental health and alcohol involvement.
- 15 February 2023
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 58 (5) , 629-636
Do Dimensional Measures of Mental Health Symptoms Predict Level of Alcohol Involvement in the General Population?
Background: There is a limited understanding of what specific mental health symptoms are associated to alcohol involvement. It is important to understand how the severity of different mental health dimensions may differ, and distinguish between, levels of alcohol involvement. Objectives: (a) explore for differences in severity of mental health symptoms between those with lower, and moderate/high alcohol involvement, (b) assess the degree to which mental health dimensions can distinguish between those with lower, and moderate/high alcohol involvement, and (c) examine what mental health dimensions are related to the highest risk of moderate/high alcohol involvement. Results: 400 participants representative of the general population in the USA were recruited online through Prolific and completed the Alcohol, Smoking and Substance Involvement Screening Test and Brief Symptom Inventory. Each of the nine mental health symptom dimensions significantly differed between lower and moderate/high alcohol involvement, with the moderate/high alcohol involvement group reporting greater severity symptoms. The nine symptom dimensions in combination also significantly distinguished lower and moderate/high alcohol involvement, however only somatization offered unique predictive utility. Lastly, global distress was also able to significantly distinguish the alcohol involvement groups, albeit to a lesser accuracy compared to the collection of individual symptom dimensions. Conclusions: These findings suggest that overall mental health distress may be important to understanding alcohol involvement, however individual symptom dimensions can add further explanatory variance. In particular, somatic symptoms may offer unique utility in understanding the relationship between mental health and alcohol involvement.
- 1 October 2022
- Published by Elsevier in Archives of Psychiatric Nursing
- Vol. 41, 333-340
Nursing staff composition and its influence on seclusion in an adult forensic mental health inpatient setting: The truth about numbers
- 1 October 2022
- Published by Elsevier in Archives of Psychiatric Nursing
- Vol. 41, 333-340
Nursing staff composition and its influence on seclusion in an adult forensic mental health inpatient setting: The truth about numbers
- Open Access
- 10 August 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (8) , 1060
Neurocognitive Artificial Neural Network Models Are Superior to Linear Models at Accounting for Dimensional Psychopathology
In recent years, there has been debate about the optimal conceptualisation of psychopathology. Structural models of psychopathology have been developed to counter issues, including comorbidity and poor diagnostic stability prevalent within the traditional nosological approach. Regardless of the conceptualisation of psychological dysfunction, deficits in neurocognitive abilities have been claimed to be an aetiological feature of psychopathology. Explorations of the association between neurocognition and psychopathology have typically taken a linear approach, overlooking the potential interactive dynamics of neurocognitive abilities. Previously, we proposed a multidimensional hypothesis, where within-person interactions between neurocognitive domains are fundamental to understanding the role of neurocognition within psychopathology. In this study, we used previously collected psychopathology data for 400 participants on psychopathological symptoms, substance use, and performance on eight neurocognitive tasks and compared the predictive accuracy of linear models to artificial neural network models. The artificial neural network models were significantly more accurate than the traditional linear models at predicting actual (a) lower-level and (b) high-level dimensional psychopathology. These results provide support for the multidimensional hypothesis: that the study of non-linear interactions and compensatory neurocognitive profiles are integral to understanding the functional associations between neurocognition and of psychopathology.
- 10 August 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (8) , 1060
Open AccessNeurocognitive Artificial Neural Network Models Are Superior to Linear Models at Accounting for Dimensional Psychopathology
In recent years, there has been debate about the optimal conceptualisation of psychopathology. Structural models of psychopathology have been developed to counter issues, including comorbidity and poor diagnostic stability prevalent within the traditional nosological approach. Regardless of the conceptualisation of psychological dysfunction, deficits in neurocognitive abilities have been claimed to be an aetiological feature of psychopathology. Explorations of the association between neurocognition and psychopathology have typically taken a linear approach, overlooking the potential interactive dynamics of neurocognitive abilities. Previously, we proposed a multidimensional hypothesis, where within-person interactions between neurocognitive domains are fundamental to understanding the role of neurocognition within psychopathology. In this study, we used previously collected psychopathology data for 400 participants on psychopathological symptoms, substance use, and performance on eight neurocognitive tasks and compared the predictive accuracy of linear models to artificial neural network models. The artificial neural network models were significantly more accurate than the traditional linear models at predicting actual (a) lower-level and (b) high-level dimensional psychopathology. These results provide support for the multidimensional hypothesis: that the study of non-linear interactions and compensatory neurocognitive profiles are integral to understanding the functional associations between neurocognition and of psychopathology.